Fig. 31From: Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s diseaseDocking pose of compounds C30–C34 at the binding site of AChE [49]Back to article page
